Navigation Links
Pull-Through Programs Critical for Maintaining Demand for Pharmaceutical Products on Managed Care Formularies
Date:3/29/2013

CHAPEL HILL, N.C., March 29, 2013 /PRNewswire/ -- In today's pharmaceutical marketplace, companies not only have to fight to win product placement on Managed Care formularies but also to "pull through" the business and increase market share after a win. To benefit from formulary wins, savvy companies ensure that their sales forces and account management teams have the necessary skills and tools to pull-through demand for favored products.

To help organizations create and maintain effective pull-through programs and processes, research and consulting leader Best Practices, LLC published "Developing Managed Care Pull-Through Excellence." This timely research identifies quantitative benchmarks and qualitative insights that will help sales and brand leaders understand how to build an effective pull-through program and leverage Managed Care contracts to generate pharmaceutical product sales.

This research investigates pull-through challenges and the best practices that companies have developed to overcome them. The research will enable pharmaceutical, bio-pharma and medical device company leadership to identify program gaps, uncover insights and discover successful best practices to share with their employees.

According to the study, while physicians are the most common group that pull-through programs are directed toward, patients also are appropriate targets. Survey respondents rate co-pays (66%) and adherence (59%) as the education topics for patient programs that have the most impact on increasing pull-through.

Topics covered in this report include:

  • How companies establish structures and processes that optimize pull-through. Areas covered include pull-through leadership, planning, training, staff roles, cross-channel and cross-functional collaboration, i
    '/>"/>

SOURCE Best Practices, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Millennium Laboratories Sponsors Educational Programs in Support of Safe Prescribing Practices at Regional Pain Society Conferences
2. Without Environmental Hygiene, Hand Hygiene Programs Fall Short in Reducing HAIs in Hospital Settings, Says UMF Corporation
3. Biodels Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office
4. DURECT Corporation Announces First Quarter 2012 Financial Results and Update of Programs
5. LifeLearn wins awards for three multimedia education programs
6. Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease
7. The Michael J. Fox Foundation Launches The $14 Million-Edmond J. Safra Core Programs for PD Research
8. Oncos Therapeutics Announces Clinical Advisory Board for its Oncolytic Virus and Cancer Immunotherapy Development Programs
9. Medical Affairs Plays Important Role in the Success of New Product Planning Programs
10. Effective Market Research Training and Development Programs Set the Stage for Global Organizational Success
11. DURECT Corporation Announces Second Quarter 2012 Financial Results and Update of Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... YORK , Sept. 16, 2014 The ... Foundation (HNF) announced today an agreement to collaborate on ... and support the development of a stronger CMT patient ... financial support to several HNF,s initiatives including: ... in the HNF website featuring  HNF newsletters, materials and ...
(Date:9/15/2014)... , Sept. 16, 2014  Bayer HealthCare and ... Finland , have begun to ... ODM-201, an investigational oral androgen receptor inhibitor in ... in men with castration-resistant prostate cancer who have ... detectable metastases. The trial is designed to determine ...
(Date:9/15/2014)... , Sept. 15, 2014 /CNW/ - Health Minister Rona ... will make available for donation over $2.5 million in personal ... aid in the global response to the Ebola outbreak in ... WHO reported a shortage of equipment in the affected countries ... by front-line workers in the affected countries. ...
Breaking Medicine Technology:Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 2Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 3Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 4Bayer and Orion Initiate Phase III Trial of ODM-201 in Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer 2Bayer and Orion Initiate Phase III Trial of ODM-201 in Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer 3Canada offers essential protective equipment to help stop the spread of Ebola in West Africa 2Canada offers essential protective equipment to help stop the spread of Ebola in West Africa 3
... 28 Having hypertension, or high blood,pressure, reduces blood ... to a new study presented today at the annual ... "While hypertension is not a cause of Alzheimer,s disease, ... brain that increases its vulnerability,to the effects of the ...
... to ... total knee replacement, MINNEAPOLIS, ... of OrthoGlide Medial Knee Implant initial,clinical data., Data representing ... was presented on November 10th, 2007 at the,American College of ...
Cached Medicine Technology:High Blood Pressure May Heighten Effects of Alzheimer's Disease 2Clinical Data Presented on OrthoGlide(R) Medial Knee Implant 2
(Date:9/16/2014)... San Diego, CA (PRWEB) September 16, 2014 ... a new hydrating lip gloss that true-ly pampers lips from ... your lips satin-smooth all day. , “The creation of true ... were suffering from dry, dehydrated lips no matter what products ... that not only looked great on, but could actually hydrate ...
(Date:9/16/2014)... DiaperBuys, a national online retailer of ... this September. Healthy Aging Month was started more than ... on the positive aspects of growing older. , ... side effects from medications that cause urinary incontinence,” explains ... DiaperBuys.com. “This can seem daunting to some patients, especially ...
(Date:9/16/2014)... September 16, 2014 Today, the Diamond ... Icon Awards to be held, Sunday, October 19, 2014 ... The annual awards show honors the dare-devil stuntwomen ... extreme sports stars. Over 12 categories will be ... ESPN’s Kenny Mayne. , Special honors will be ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 ... monthly specials this month, kicking off September with ... spa in Clearwater, FL chose to highlight lumablanc® ... immediate activation upon contact with the skin. , ... of their best-selling lumafirm® anti-aging line. The brightening ...
(Date:9/16/2014)... 2014 Banish headaches forever with the ... Cefaly device for chronic migraine relief and treatment. Cefaly ... United States. Until now, US patients would directly place ... Belgium and wait 2-3 weeks for their device to ... States and once prescription and payment is received, the ...
Breaking Medicine News(10 mins):Health News:True Science Cosmetics, LLC Launches True Lipz™ 2Health News:DiaperBuys Honors ‘Healthy Aging’ Month throughout September 2Health News:DiaperBuys Honors ‘Healthy Aging’ Month throughout September 3Health News:Hollywood's Action Icon Awards to Honor Legendary Stuntwomen In A Star-Studded Gala and Awards Ceremony 2Health News:Botanica Day Spa Rolls Out September Specials Highlighting Lumablanc® by Pevonia 2Health News:Botanica Day Spa Rolls Out September Specials Highlighting Lumablanc® by Pevonia 3Health News:Cefaly Migraine Treatment Device Now Readily Available For Widespread Purchase in United States 2
... Oregon Health & Science University,s Vaccine and Gene Therapy Institute ... of infection before it becomes a rapidly replicating, ... the spread of the disease. The research is published in ... and will appear in a future printed edition. ...
... Bob Woodruff was injured while reporting in Iraq in 2006, ... his ability to recall and produce common words a ... language skills thanks to intensive behavioral therapy reading and ... for patients with aphasia has always been and will always ...
... Martek Biosciences Corporation (Nasdaq: MATK ) announced ... quarter of fiscal 2009 on March 4, 2009, at approximately ... 4:45 p.m. ET Martek will conduct a conference call to ... listen to the call live via webcast by visiting Martek,s ...
... but not available in U.S., was stopped early due ... -- A large study of tibolone, a drug used ... halted early after researchers found that the synthetic steroid ... survivors of the disease. , Tibolone isn,t available in ...
... Patient Check-In Company(TM), the leader in patient-intake, announced ... bringing total investment to date to $25 million. ... fund of the BlueCross BlueShield Association, and Sandbox ... Venture Partners, HLM Venture Partners, and Long River ...
... pathway that is responsible for generating excess connective tissue ... human patients with scleroderma. The study, published by Cell ... Developmental Cell , also reveals an intriguing but unexpected ... disease. , Platelet derived growth factors (PDGF) regulate ...
Cached Medicine News:Health News:OHSU vaccine research targets HIV in the slower, early stage of infection 2Health News:Exploring new pathways to language 2Health News:Menopause Drug Tied to Breast Cancer Recurrence 2Health News:Phreesia Secures $11.6M Series C Funding Led by BlueCross BlueShield Venture Partners and Sandbox Industries 2Health News:Phreesia Secures $11.6M Series C Funding Led by BlueCross BlueShield Venture Partners and Sandbox Industries 3Health News:Phreesia Secures $11.6M Series C Funding Led by BlueCross BlueShield Venture Partners and Sandbox Industries 4Health News:Tumor suppressor may attenuate fibrotic disease 2
For the quantitative determination of Iron and IBC in serum. Colorimetric method utilizing ferrozine. Endpoint procedure measured at 560 nm. Linearity: 500 ug/dl....
HDL Cholesterol (PEG) Precip. Reagent + 5 ml of 50 mg/dl cholesterol std....
Intended for the quantitative in vitro enzymatic determination of JDL-Cholesterol in human serum or plasma. Two point reaction. Wavelength: 600 nm. Linearity: 1 to 150 mg/dL (0.03 mmol/L to 3.89 mmol...
... Intended for the quantitative ... plasma. Two vials, dry ... alphaketoglutarate. Uses NADPH to ... plasma compounds. Reaction: Enzymatic, ...
Medicine Products: